A Roundtable Discussion on the Clinical Challenges and Options for the Treatment of Glioblastoma: Introducing a Novel Modality, TTFields

Holland, 2000, Glioblastoma multiforme: The terminator, Proc Natl Acad Sci U S A, 97, 6242, 10.1073/pnas.97.12.6242 Gutin PH, Wong ET. Noninvasive application of alternating electric fields in glioblastoma: a fourth cancer treatment modality. ASCO. Chicago, IL; June 1--5, 2012 Wen, 2008, Malignant gliomas in adults, N Engl J Med, 359, 492, 10.1056/NEJMra0708126 Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987, 10.1056/NEJMoa043330 Central nervous system cancers. NCCN Guidelines Version 2.2013. Stupp, 2009, Effects of radiotherapy with concomitant and adjuvant Temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet Oncol, 10, 459, 10.1016/S1470-2045(09)70025-7 Chamberlain, 2011, Bevacizumab for the treatment of recurrent glioblastoma, Clin Med Insights Oncol, 5, 117, 10.4137/CMO.S7232 Norden, 2008, Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence, Neurology, 70, 779, 10.1212/01.wnl.0000304121.57857.38 Fonkem, 2012, NovoTTF-100A: a new treatment modality for recurrent glioblastoma, Expert Rev Neurother, 12, 895, 10.1586/ern.12.80 Palti, 2007, Management of recurrent or progressive glioblastoma multiforme with low-intensity, medium-frequency alternating electric fields, Eur Oncol Dis, 88 Kirson, 2004, Disruption of cancer cell replication by alternating electric fields, Cancer Res, 64, 3288, 10.1158/0008-5472.CAN-04-0083 Instructions for Use. NovoTTF-100A system. Novocure. Issue date: May 12, 2013. Kirson, 2007, Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors, Proc Natl Acad Sci U S A, 104, 10152, 10.1073/pnas.0702916104 Kirson, 2009, Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields), BMC Med Phys, 9, 10.1186/1756-6649-9-1 Stupp, 2012, NovoTTF-100A versus physicians’ choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality, Eur J Cancer, 48, 2192, 10.1016/j.ejca.2012.04.011